IMV Inc. Logo

IMV Inc.

IMV

(1.0)
Stock Price

0,82 USD

-122.79% ROA

-515.29% ROE

-0.18x PER

Market Cap.

9.632.791,00 USD

-437.7% DER

0% Yield

0% NPM

IMV Inc. Stock Analysis

IMV Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

IMV Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (-102.6x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (-438%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

Negative ROE (-12236.93%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-116.81%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

IMV Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

IMV Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

IMV Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

IMV Inc. Revenue
Year Revenue Growth
2007 0
2008 0 0%
2009 6.891 100%
2010 76.092 90.95%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 93.466 100%
2016 96.498 3.14%
2017 0 0%
2018 60.204 100%
2019 45.166 -33.29%
2020 2.353 -1820.32%
2021 0 0%
2022 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

IMV Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 3.779.793 100%
2011 4.153.164 8.99%
2012 3.351.314 -23.93%
2013 2.387.493 -40.37%
2014 3.053.213 21.8%
2015 3.293.276 7.29%
2016 2.589.869 -27.16%
2017 4.695.875 44.85%
2018 9.435.915 50.23%
2019 14.534.514 35.08%
2020 20.864.048 30.34%
2021 23.080.000 9.6%
2022 18.536.000 -24.51%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

IMV Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 0 0%
2009 74.910 100%
2010 3.312.799 97.74%
2011 0 0%
2012 2.960.526 100%
2013 2.529.592 -17.04%
2014 2.387.420 -5.96%
2015 2.834.292 15.77%
2016 2.859.735 0.89%
2017 5.109.161 44.03%
2018 6.786.194 24.71%
2019 7.762.560 12.58%
2020 11.923.993 34.9%
2021 16.020.000 25.57%
2022 17.152.000 6.6%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

IMV Inc. EBITDA
Year EBITDA Growth
2007 -54.575
2008 -21.234 -157.02%
2009 -61.505 65.48%
2010 -7.016.500 99.12%
2011 -6.347.467 -10.54%
2012 -6.177.600 -2.75%
2013 -4.809.160 -28.45%
2014 -5.351.976 10.14%
2015 -5.962.252 10.24%
2016 -5.274.866 -13.03%
2017 -8.685.786 39.27%
2018 -14.849.159 41.51%
2019 -19.596.255 24.22%
2020 -26.901.722 27.16%
2021 -35.141.000 23.45%
2022 -33.072.000 -6.26%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

IMV Inc. Gross Profit
Year Gross Profit Growth
2007 0
2008 0 0%
2009 6.891 100%
2010 76.092 90.95%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 93.466 100%
2016 96.498 3.14%
2017 0 0%
2018 60.204 100%
2019 45.166 -33.29%
2020 2.353 -1820.32%
2021 0 0%
2022 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

IMV Inc. Net Profit
Year Net Profit Growth
2007 -54.575
2008 -9.252 -489.94%
2009 -61.505 84.96%
2010 -5.869.575 98.95%
2011 -6.666.112 11.95%
2012 -6.433.095 -3.62%
2013 -4.396.661 -46.32%
2014 -5.657.649 22.29%
2015 -4.273.235 -32.4%
2016 -6.763.491 36.82%
2017 -9.565.303 29.29%
2018 -17.121.502 44.13%
2019 -21.897.464 21.81%
2020 -27.362.057 19.97%
2021 -37.496.000 27.03%
2022 -34.360.000 -9.13%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

IMV Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 0
2008 0 0%
2009 0 0%
2010 -4 100%
2011 -4 0%
2012 -3 0%
2013 -2 -50%
2014 -2 0%
2015 -1 -100%
2016 -2 50%
2017 -2 0%
2018 -4 33.33%
2019 -4 25%
2020 0 0%
2021 -5 100%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

IMV Inc. Free Cashflow
Year Free Cashflow Growth
2007 -33.586
2008 -24.270 -38.39%
2009 -71.766 66.18%
2010 -5.610.373 98.72%
2011 -5.322.241 -5.41%
2012 -5.711.840 6.82%
2013 -4.495.756 -27.05%
2014 -4.253.248 -5.7%
2015 -5.180.114 17.89%
2016 -4.581.317 -13.07%
2017 -7.460.868 38.6%
2018 -14.215.546 47.52%
2019 -21.254.411 33.12%
2020 -27.594.184 22.98%
2021 -33.447.000 17.5%
2022 -6.508.000 -413.94%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

IMV Inc. Operating Cashflow
Year Operating Cashflow Growth
2007 -33.586
2008 -24.270 -38.39%
2009 -71.766 66.18%
2010 -5.521.179 98.7%
2011 -5.156.338 -7.08%
2012 -5.681.355 9.24%
2013 -4.489.509 -26.55%
2014 -4.219.722 -6.39%
2015 -5.092.912 17.15%
2016 -4.498.650 -13.21%
2017 -7.153.379 37.11%
2018 -12.611.323 43.28%
2019 -20.890.015 39.63%
2020 -27.247.561 23.33%
2021 -32.045.000 14.97%
2022 -6.301.000 -408.57%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

IMV Inc. Capital Expenditure
Year Capital Expenditure Growth
2007 0
2008 0 0%
2009 0 0%
2010 89.195 100%
2011 165.903 46.24%
2012 30.486 -444.21%
2013 6.246 -388.07%
2014 33.526 81.37%
2015 87.202 61.55%
2016 82.667 -5.49%
2017 307.489 73.12%
2018 1.604.223 80.83%
2019 364.396 -340.24%
2020 346.623 -5.13%
2021 1.402.000 75.28%
2022 207.000 -577.29%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

IMV Inc. Equity
Year Equity Growth
2007 418.774
2008 565.120 25.9%
2009 486.614 -16.13%
2010 4.885.126 90.04%
2011 4.947.671 1.26%
2012 1.818.667 -172.05%
2013 2.433.168 25.26%
2014 6.731.081 63.85%
2015 49.980 -13367.55%
2016 5.195.453 99.04%
2017 5.043.743 -3.01%
2018 3.169.533 -59.13%
2019 4.936.192 35.79%
2020 30.878.477 84.01%
2021 21.542.000 -43.34%
2022 -6.602.000 426.3%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

IMV Inc. Assets
Year Assets Growth
2007 440.448
2008 571.097 22.88%
2009 743.533 23.19%
2010 12.711.201 94.15%
2011 6.994.715 -81.73%
2012 3.869.920 -80.75%
2013 4.786.277 19.15%
2014 10.723.480 55.37%
2015 4.289.191 -150.01%
2016 11.234.934 61.82%
2017 13.544.085 17.05%
2018 16.831.494 19.53%
2019 17.174.091 1.99%
2020 46.111.860 62.76%
2021 50.121.000 8%
2022 31.348.000 -59.89%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

IMV Inc. Liabilities
Year Liabilities Growth
2007 21.673
2008 5.977 -262.67%
2009 256.918 97.67%
2010 7.826.074 96.72%
2011 2.047.044 -282.31%
2012 2.051.252 0.21%
2013 2.353.109 12.83%
2014 3.992.399 41.06%
2015 4.239.210 5.82%
2016 6.039.481 29.81%
2017 8.500.341 28.95%
2018 13.661.960 37.78%
2019 12.237.898 -11.64%
2020 15.233.382 19.66%
2021 28.579.000 46.7%
2022 37.950.000 24.69%

IMV Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-4.61
Price to Earning Ratio
-0.18x
Price To Sales Ratio
0x
POCF Ratio
-0.21
PFCF Ratio
-0.28
Price to Book Ratio
-1.04
EV to Sales
0
EV Over EBITDA
-0.45
EV to Operating CashFlow
-0.52
EV to FreeCashFlow
-0.5
Earnings Yield
-5.61
FreeCashFlow Yield
-3.58
Market Cap
0,01 Bil.
Enterprise Value
0,02 Bil.
Graham Number
9.06
Graham NetNet
-1.83

Income Statement Metrics

Net Income per Share
-4.61
Income Quality
0.88
ROE
-5.15
Return On Assets
-1.23
Return On Capital Employed
-1.8
Net Income per EBT
1.01
EBT Per Ebit
0.96
Ebit per Revenue
0
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-4
Free CashFlow per Share
-4.13
Capex to Operating CashFlow
0.03
Capex to Revenue
0
Capex to Depreciation
-1.07
Return on Invested Capital
-1.79
Return on Tangible Assets
-1.23
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0.13

Balance Sheet

Cash per Share
2,54
Book Value per Share
-0,79
Tangible Book Value per Share
-0.79
Shareholders Equity per Share
-0.79
Interest Debt per Share
3.52
Debt to Equity
-4.38
Debt to Assets
0.92
Net Debt to EBITDA
-0.2
Current Ratio
2.93
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-4.38
Working Capital
0,02 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
3

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

IMV Inc. Dividends
Year Dividends Growth

IMV Inc. Profile

About IMV Inc.

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

CEO
Mr. Andrew Hall M.Sc.
Employee
63
Address
130 Eileen Stubbs Avenue
Dartmouth, B3B 2C4

IMV Inc. Executives & BODs

IMV Inc. Executives & BODs
# Name Age
1 Dr. Jeremy R. Graff
Chief Scientific Officer
70
2 Mr. Andrew Hall M.Sc.
Chief Executive Officer & Director
70
3 Dr. Marianne Stanford
Vice President of R&D
70
4 Ms. Brittany Davison C.A., C.P.A.
Chief Accounting Officer, Corporation Sec. & Director
70
5 Dr. Heather Hirsch
Vice President of Translational Research
70
6 Delphine Davan
Senior Director of Communications & Investor Relations
70
7 Mr. Stephan Fiset
Vice President of Clinical Research
70
8 Dr. Heather Hirsch Ph.D.
Vice President of Translational Research
70
9 Dr. Jeremy R. Graff Ph.D.
Chief Scientific Officer
70
10 Ms. Jennifer Schmitke Ph.D.
Acting Chief Operating Officer
70
11 Mr. Stephan Fiset M.B.A., M.Sc.
Vice President of Clinical Research
70
12 Ms. Brittany Davison C.A., CPA
Chief Accounting Officer, Corporation Sec. & Director
70
13 Ms. Linda Barabe M.B.A.
Senior Vice President of HR
70

IMV Inc. Competitors